Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Dec 20, 2020 11:37am
128 Views
Post# 32149063

RE:Question for longs

RE:Question for longsDivide by 8, those are preconsolidation option values.
GrahamB wrote: Hi all,
Starting due diligence on this company, as I came to it indirectly,.
So take this as being naive, but in my checklist, I start with finacials, share structure, and related party transactions.
Also note-I post on facts only-although some take factual discussion of finacials to be negative-according to a value based approach it is objective and fact based.

The first area I had questions relates to the growth in shares, warrants, and likleihood of increasing share issuance to fund operations.

In terms of shares Outstanding:

 

Significant growth ~7million to ~50 million.

Insiders have been granted almost 10 million shares in the last  4 months.

This growth is providing financing which they require to survive (as indicated on the MD&A) but is  also dilutive of existing shareholders.

 

As part of the refiling for errors in the financials it is noted in the MD&A:

Share-based Compensation The Company has identified an error relating to the vesting of stock options, which resulted in an understatement of share-based compensation for the nine months period ended September 30, 2019. 

Source:Sedar.com

 

There were other errors related to the filings with the Ontario Securities Commission, and a change of auditor.

 

 Change of auditor and announced refiling of financials

 

https://www.osc.gov.on.ca/documents/en/Investors-Errors-Refilings/er_nr_20221117_stagezero.pdf

 

 

 

Filing

Date

Transaction

Date

Insider Name

Ownership

Type

Securities

Nature of transaction

Volume or Value

Price

Aug 10/20

Aug 10/20

Glorikian, Harry

Direct Ownership

Options

50 - Grant of options

500,000

$0.055

Aug 10/20

Aug 7/20

Solomon, Carl

Direct Ownership

Options

50 - Grant of options

100,000

$0.055

Aug 10/20

Aug 7/20

Riggs, Rory

Direct Ownership

Options

50 - Grant of options

3,500,000

$0.055

Aug 10/20

Aug 7/20

MacRae, Garth A. C.

Direct Ownership

Options

50 - Grant of options

500,000

$0.055

Aug 10/20

Aug 7/20

Howard-Tripp, James

Direct Ownership

Options

50 - Grant of options

5,000,000

$0.05

Canadian insider.com

What do longs think of this?
Did you dismiss this because of the growth potential?

To keep this post from getting too long-will do a sperate post on the revenue/loss metrics, if this is worth it



<< Previous
Bullboard Posts
Next >>